Peptide Therapeutics Market - Global Outlook and Forecast 2021-2027

January 2021 | 107 pages | ID: PA81A8B9812AEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Peptide Therapeutics in Global, including the following market information:
Global Peptide Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Peptide Therapeutics market was valued at 34080 million in 2020 and is projected to reach US$ 39900 million by 2027, at a CAGR of 4.0% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Peptide Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Peptide Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Peptide Therapeutics Market Segment Percentages, By Type, 2020 (%)

• Injection
• Oral
• Other

China Peptide Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Peptide Therapeutics Market Segment Percentages, By Application, 2020 (%)

• Cancer
• Metabolic Disorders
• Central Nervous System
• Other

Global Peptide Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Peptide Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Peptide Therapeutics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Peptide Therapeutics Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Sanofi
• Eli Lilly
• Novo Nordisk
• Takeda
• Teva
• Novartis
• AstraZeneca
• Ipsen
• AbbVie
• Allergan
• Ferring
• Merck
• J & J
• The Medicines

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Peptide Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Peptide Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PEPTIDE THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Peptide Therapeutics Market Size: 2021 VS 2027
2.2 Global Peptide Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Peptide Therapeutics Players in Global Market
3.2 Top Global Peptide Therapeutics Companies Ranked by Revenue
3.3 Global Peptide Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Peptide Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Peptide Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Peptide Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Peptide Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Peptide Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Peptide Therapeutics Market Size Markets, 2021 & 2027
  4.1.2 Injection
  4.1.3 Oral
  4.1.4 Other
4.2 By Type - Global Peptide Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Peptide Therapeutics Revenue, 2016-2021
  4.2.2 By Type - Global Peptide Therapeutics Revenue, 2022-2027
  4.2.3 By Type - Global Peptide Therapeutics Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Peptide Therapeutics Market Size, 2021 & 2027
  5.1.2 Cancer
  5.1.3 Metabolic Disorders
  5.1.4 Central Nervous System
  5.1.5 Other
5.2 By Application - Global Peptide Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Peptide Therapeutics Revenue, 2016-2021
  5.2.2 By Application - Global Peptide Therapeutics Revenue, 2022-2027
  5.2.3 By Application - Global Peptide Therapeutics Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Peptide Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global Peptide Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Peptide Therapeutics Revenue, 2016-2021
  6.2.2 By Region - Global Peptide Therapeutics Revenue, 2022-2027
  6.2.3 By Region - Global Peptide Therapeutics Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Peptide Therapeutics Revenue, 2016-2027
  6.3.2 US Peptide Therapeutics Market Size, 2016-2027
  6.3.3 Canada Peptide Therapeutics Market Size, 2016-2027
  6.3.4 Mexico Peptide Therapeutics Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Peptide Therapeutics Revenue, 2016-2027
  6.4.2 Germany Peptide Therapeutics Market Size, 2016-2027
  6.4.3 France Peptide Therapeutics Market Size, 2016-2027
  6.4.4 U.K. Peptide Therapeutics Market Size, 2016-2027
  6.4.5 Italy Peptide Therapeutics Market Size, 2016-2027
  6.4.6 Russia Peptide Therapeutics Market Size, 2016-2027
  6.4.7 Nordic Countries Peptide Therapeutics Market Size, 2016-2027
  6.4.8 Benelux Peptide Therapeutics Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Peptide Therapeutics Revenue, 2016-2027
  6.5.2 China Peptide Therapeutics Market Size, 2016-2027
  6.5.3 Japan Peptide Therapeutics Market Size, 2016-2027
  6.5.4 South Korea Peptide Therapeutics Market Size, 2016-2027
  6.5.5 Southeast Asia Peptide Therapeutics Market Size, 2016-2027
  6.5.6 India Peptide Therapeutics Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Peptide Therapeutics Revenue, 2016-2027
  6.6.2 Brazil Peptide Therapeutics Market Size, 2016-2027
  6.6.3 Argentina Peptide Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Peptide Therapeutics Revenue, 2016-2027
  6.7.2 Turkey Peptide Therapeutics Market Size, 2016-2027
  6.7.3 Israel Peptide Therapeutics Market Size, 2016-2027
  6.7.4 Saudi Arabia Peptide Therapeutics Market Size, 2016-2027
  6.7.5 UAE Peptide Therapeutics Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Sanofi
  7.1.1 Sanofi Corporate Summary
  7.1.2 Sanofi Business Overview
  7.1.3 Sanofi Peptide Therapeutics Major Product Offerings
  7.1.4 Sanofi Peptide Therapeutics Revenue in Global (2016-2021)
  7.1.5 Sanofi Key News
7.2 Eli Lilly
  7.2.1 Eli Lilly Corporate Summary
  7.2.2 Eli Lilly Business Overview
  7.2.3 Eli Lilly Peptide Therapeutics Major Product Offerings
  7.2.4 Eli Lilly Peptide Therapeutics Revenue in Global (2016-2021)
  7.2.5 Eli Lilly Key News
7.3 Novo Nordisk
  7.3.1 Novo Nordisk Corporate Summary
  7.3.2 Novo Nordisk Business Overview
  7.3.3 Novo Nordisk Peptide Therapeutics Major Product Offerings
  7.3.4 Novo Nordisk Peptide Therapeutics Revenue in Global (2016-2021)
  7.3.5 Novo Nordisk Key News
7.4 Takeda
  7.4.1 Takeda Corporate Summary
  7.4.2 Takeda Business Overview
  7.4.3 Takeda Peptide Therapeutics Major Product Offerings
  7.4.4 Takeda Peptide Therapeutics Revenue in Global (2016-2021)
  7.4.5 Takeda Key News
7.5 Teva
  7.5.1 Teva Corporate Summary
  7.5.2 Teva Business Overview
  7.5.3 Teva Peptide Therapeutics Major Product Offerings
  7.5.4 Teva Peptide Therapeutics Revenue in Global (2016-2021)
  7.5.5 Teva Key News
7.6 Novartis
  7.6.1 Novartis Corporate Summary
  7.6.2 Novartis Business Overview
  7.6.3 Novartis Peptide Therapeutics Major Product Offerings
  7.6.4 Novartis Peptide Therapeutics Revenue in Global (2016-2021)
  7.6.5 Novartis Key News
7.7 AstraZeneca
  7.7.1 AstraZeneca Corporate Summary
  7.7.2 AstraZeneca Business Overview
  7.7.3 AstraZeneca Peptide Therapeutics Major Product Offerings
  7.4.4 AstraZeneca Peptide Therapeutics Revenue in Global (2016-2021)
  7.7.5 AstraZeneca Key News
7.8 Ipsen
  7.8.1 Ipsen Corporate Summary
  7.8.2 Ipsen Business Overview
  7.8.3 Ipsen Peptide Therapeutics Major Product Offerings
  7.8.4 Ipsen Peptide Therapeutics Revenue in Global (2016-2021)
  7.8.5 Ipsen Key News
7.9 AbbVie
  7.9.1 AbbVie Corporate Summary
  7.9.2 AbbVie Business Overview
  7.9.3 AbbVie Peptide Therapeutics Major Product Offerings
  7.9.4 AbbVie Peptide Therapeutics Revenue in Global (2016-2021)
  7.9.5 AbbVie Key News
7.10 Allergan
  7.10.1 Allergan Corporate Summary
  7.10.2 Allergan Business Overview
  7.10.3 Allergan Peptide Therapeutics Major Product Offerings
  7.10.4 Allergan Peptide Therapeutics Revenue in Global (2016-2021)
  7.10.5 Allergan Key News
7.11 Ferring
  7.11.1 Ferring Corporate Summary
  7.11.2 Ferring Business Overview
  7.11.3 Ferring Peptide Therapeutics Major Product Offerings
  7.11.4 Ferring Peptide Therapeutics Revenue in Global (2016-2021)
  7.11.5 Ferring Key News
7.12 Merck
  7.12.1 Merck Corporate Summary
  7.12.2 Merck Business Overview
  7.12.3 Merck Peptide Therapeutics Major Product Offerings
  7.12.4 Merck Peptide Therapeutics Revenue in Global (2016-2021)
  7.12.5 Merck Key News
7.13 J & J
  7.13.1 J & J Corporate Summary
  7.13.2 J & J Business Overview
  7.13.3 J & J Peptide Therapeutics Major Product Offerings
  7.13.4 J & J Peptide Therapeutics Revenue in Global (2016-2021)
  7.13.5 J & J Key News
7.14 The Medicines
  7.14.1 The Medicines Corporate Summary
  7.14.2 The Medicines Business Overview
  7.14.3 The Medicines Peptide Therapeutics Major Product Offerings
  7.14.4 The Medicines Peptide Therapeutics Revenue in Global (2016-2021)
  7.14.5 The Medicines Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Peptide Therapeutics Market Opportunities & Trends in Global Market
Table 2. Peptide Therapeutics Market Drivers in Global Market
Table 3. Peptide Therapeutics Market Restraints in Global Market
Table 4. Key Players of Peptide Therapeutics in Global Market
Table 5. Top Peptide Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Peptide Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Peptide Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Peptide Therapeutics Product Type
Table 9. List of Global Tier 1 Peptide Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Peptide Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Peptide Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Peptide Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Peptide Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Peptide Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Peptide Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Peptide Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Peptide Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Peptide Therapeutics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Peptide Therapeutics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Peptide Therapeutics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Peptide Therapeutics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Peptide Therapeutics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Peptide Therapeutics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Peptide Therapeutics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Peptide Therapeutics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Peptide Therapeutics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Peptide Therapeutics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Peptide Therapeutics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Peptide Therapeutics Revenue, (US$, Mn), 2022-2027
Table 30. Sanofi Corporate Summary
Table 31. Sanofi Peptide Therapeutics Product Offerings
Table 32. Sanofi Peptide Therapeutics Revenue (US$, Mn), (2016-2021)
Table 33. Eli Lilly Corporate Summary
Table 34. Eli Lilly Peptide Therapeutics Product Offerings
Table 35. Eli Lilly Peptide Therapeutics Revenue (US$, Mn), (2016-2021)
Table 36. Novo Nordisk Corporate Summary
Table 37. Novo Nordisk Peptide Therapeutics Product Offerings
Table 38. Novo Nordisk Peptide Therapeutics Revenue (US$, Mn), (2016-2021)
Table 39. Takeda Corporate Summary
Table 40. Takeda Peptide Therapeutics Product Offerings
Table 41. Takeda Peptide Therapeutics Revenue (US$, Mn), (2016-2021)
Table 42. Teva Corporate Summary
Table 43. Teva Peptide Therapeutics Product Offerings
Table 44. Teva Peptide Therapeutics Revenue (US$, Mn), (2016-2021)
Table 45. Novartis Corporate Summary
Table 46. Novartis Peptide Therapeutics Product Offerings
Table 47. Novartis Peptide Therapeutics Revenue (US$, Mn), (2016-2021)
Table 48. AstraZeneca Corporate Summary
Table 49. AstraZeneca Peptide Therapeutics Product Offerings
Table 50. AstraZeneca Peptide Therapeutics Revenue (US$, Mn), (2016-2021)
Table 51. Ipsen Corporate Summary
Table 52. Ipsen Peptide Therapeutics Product Offerings
Table 53. Ipsen Peptide Therapeutics Revenue (US$, Mn), (2016-2021)
Table 54. AbbVie Corporate Summary
Table 55. AbbVie Peptide Therapeutics Product Offerings
Table 56. AbbVie Peptide Therapeutics Revenue (US$, Mn), (2016-2021)
Table 57. Allergan Corporate Summary
Table 58. Allergan Peptide Therapeutics Product Offerings
Table 59. Allergan Peptide Therapeutics Revenue (US$, Mn), (2016-2021)
Table 60. Ferring Corporate Summary
Table 61. Ferring Peptide Therapeutics Product Offerings
Table 62. Ferring Peptide Therapeutics Revenue (US$, Mn), (2016-2021)
Table 63. Merck Corporate Summary
Table 64. Merck Peptide Therapeutics Product Offerings
Table 65. Merck Peptide Therapeutics Revenue (US$, Mn), (2016-2021)
Table 66. J & J Corporate Summary
Table 67. J & J Peptide Therapeutics Product Offerings
Table 68. J & J Peptide Therapeutics Revenue (US$, Mn), (2016-2021)
Table 69. The Medicines Corporate Summary
Table 70. The Medicines Peptide Therapeutics Product Offerings
Table 71. The Medicines Peptide Therapeutics Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Peptide Therapeutics Segment by Type
Figure 2. Peptide Therapeutics Segment by Application
Figure 3. Global Peptide Therapeutics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Peptide Therapeutics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Peptide Therapeutics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Peptide Therapeutics Revenue in 2020
Figure 8. By Type - Global Peptide Therapeutics Revenue Market Share, 2016-2027
Figure 9. By Application - Global Peptide Therapeutics Revenue Market Share, 2016-2027
Figure 10. By Region - Global Peptide Therapeutics Revenue Market Share, 2016-2027
Figure 11. By Country - North America Peptide Therapeutics Revenue Market Share, 2016-2027
Figure 12. US Peptide Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Peptide Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Peptide Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Peptide Therapeutics Revenue Market Share, 2016-2027
Figure 16. Germany Peptide Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 17. France Peptide Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Peptide Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Peptide Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Peptide Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Peptide Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Peptide Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Peptide Therapeutics Revenue Market Share, 2016-2027
Figure 24. China Peptide Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Peptide Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Peptide Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Peptide Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 28. India Peptide Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Peptide Therapeutics Revenue Market Share, 2016-2027
Figure 30. Brazil Peptide Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Peptide Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Peptide Therapeutics Revenue Market Share, 2016-2027
Figure 33. Turkey Peptide Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Peptide Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Peptide Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Peptide Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 37. Sanofi Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Eli Lilly Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Novo Nordisk Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Takeda Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Teva Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Novartis Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. AstraZeneca Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Ipsen Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. AbbVie Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Allergan Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Ferring Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Merck Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. J & J Peptide Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)